Home > > > > > Report Detail

Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019)

Publisher Name :
Date: 01-Aug-2015
No. of pages: 80

Scope of the report

The report titled “Global In-Vitro-Fertilization (IVF) Market: Trends and Opportunities (2015-2019)”, analyzes the potential opportunities and significant trends in the global in- vitro-fertilization market. The market size and forecast in value terms and number of IVF cycles for global IVF market has been provided for the period 2010 to 2019, considering 2014 as the base year. The report provides market share analysis of the global IVF market by regions, treatment costs, players and segments. The market is further segment by drug mechanism and different dosage forms.

The report provides detailed country analysis of the IVF markets of Australia, India and the United States. The market size and forecast both in terms of value and volume is covered in the country analysis segment. Also, the various factors driving growth have been analyzed specific to each country.

The report also profiles key market players such as Vitrolife, Monash IVF and OvaScience on the basis of attributes such as company overview, recent developments, strategies adopted by the market leaders to ensure growth, sustainability, financial overview and recent developments.

Country Coverage


  • United States

  • India

  • Australia


Company Coverage


  • Monash Group

  • OvaScience

  • Vitrolife


Executive Summary

IVF stands for in-vitro-fertilization and refers to artificial fertilization for people that want to have a baby but are having difficulty getting pregnant.

Rising incidences of infertility as a consequence of increasing maternal age as more women are now starting families later in life is leading to a rise in demand for IVF treatment. Furthermore, lifestyle induced disorders such as obesity and smoking are contributing towards high infertility rates. These together are thus driving the in-vitro fertilization market, as women and their families prefer in-vitro fertilization procedure more compared to the other available procedures. The global in-vitro fertilization market is also witnessing lucrative growth with an increase in medical tourism activities in the developing economies such as India, China and Brazil. The major limiting factor of IVF market is the cost involved in the treatment. Another challenge is the low level of awareness in the developing economies.

The US emerged as the highest revenue contributing regional market for IVF in 2013. The growth of this market in the region is attributed to the presence of large population base suffering from infertility. Moreover, the availability of high disposable income with the people of this region is contributing to the growth of the IVF market. Asia Pacific is expected to grow at a highest CAGR over the forecasted period of 2015-2019 because of the presence of unmet medical needs coupled with favorable government initiatives pertaining to the development of healthcare infrastructure in emerging economies such as India, China and Japan. Australia has the highest market value and number of IVF cycles in the Asia-Pacific region. Furthermore, increasing medical tourism and availability of cost effective medical procedures in India are expected to positively reinforce In-Vitro fertilization market.

Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019)

Table of Contents

1. Executive Summary

2. In-Vitro-Fertilization (IVF): An Introduction
2.1 IVF Treatment Procedure    
2.2 Causes of Infertility    
2.3 Risk Related to IVF Treatment    
2.3.1 Multiple Births    
2.3.2 Premature Delivery and Low Birth Weight    
2.3.3 Ovarian Hyperstimulation Syndrome    
2.3.4 Miscarriage    
2.3.5 Egg-Retrieval Procedure Complications    
2.3.6 Ectopic Pregnancy    
2.3.7 Birth Defects    
2.3.8 Ovarian Cancer    
2.3.9 Stress   

3. In-Vitro-Fertilization (IVF): Global Market Analysis    
3.1 Global IVF Market – Sizing and Growth: Actual & Forecast    
3.2 Global IVF Market Share: An Analysis    
3.2.1 Global IVF Market Share by IVF Cycles per Region    
3.2.2 Global IVF Treatment Cost by Regions    
3.2.3 Global Fertility Rates by Regions    
3.2.4 Global IVF Penetration by Regions
3.2.5 Global IVF Market by Segments    
3.2.6 Global IVF Market by Key Players    

4. Country Analysis: In-Vitro-Fertilization (IVF) Market
4.1 Australia IVF Market: An Analysis    
4.1.1 Australia IVF Market: Actual & Forecast    
By Value    
By Number of IVF Cycles    
4.1.2 Australia IVF Market Drivers
Reproductive Age of Women
Increasing Penetration (% of women opting for IVF over natural conception)
Increasing Social Acceptance & Awareness
Fertility Rate
Affordability
4.2 India IVF Market: An Analysis
4.2.1 India IVF Market: Actual & Forecast
By Value
By Number of IVF Cycles
4.2.2 India IVF Market Drivers
Increasing Fertility Tourism
Declining Fertility Rate
Affordability
4.3 The US IVF Market: An Analysis
4.3.1 The US IVF Market: Actual and Forecast
By Value
By Number of IVF Procedures
By Number of Infants Births by Using IVF
4.3.2 The US IVF Market Breakdown
By Age Group
By Number of Embryos Transferred
4.3.3 The US IVF Market Drivers
Birth Rates
Declining Fertility Rates
Increasing Same Sex Married Couples
Obesity
4.3.4 US IVF Industry Landscape and M&A Activity

5. Market Dynamics: In-Vitro-Fertilization (IVF) Market
5.1 Growth Drivers
5.1.1 Decline in Fertility Rates
5.1.2 Delay in Motherhood
5.1.3 Rising Healthcare Expenditure
5.1.4 IVF Success Rates
5.2 Challenges
5.2.1 Physical and Emotional Impact
5.2.2 Legal Issues
5.2.3 Ethical Issues
5.2.4 Clinical Issues
5.2.5 Cost of the Treatment
5.2.6 Multiple Pregnancies
5.3 Market Trends
5.3.1 Medical Tourism
5.3.2 New Technology Trends
Robotic Surgery Used in Tubal Reversal
Transfer of Vitrified Embryos
Surrogate Alternatives
5.3.3 Rise in Same Sex Marriages

6. Competitive Landscape: In-Vitro-Fertilization (IVF) Market

7. Company Profiles: In-Vitro-Fertilization (IVF) Market
7.1 Monash
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Vitrolife
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 OvaScience
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy

List of Tables

Table 1: India IVF Market Statistics; 2014 & 2020
Table 2: Obesity-Related Fertility Issues
Table 3: M&A Activity in IVF Industry in the US
Table 4: Comparative Analysis of IVF Industry Players; 2014

List of Figures

Figure 1: IVF Treatment Procedure
Figure 2: Causes of Infertility; 2013
Figure 3: Global Rate of Natural Conception by Age Group over a Year (%); 2014
Figure 4: Global IVF Market by Value; 2012-2014 (US$ Billion)
Figure 5: Global IVF Market by Value; 2015E-2019E (US$ Billion)
Figure 6: Global IVF Market Share by IVF Cycles per Regions; 2013
Figure 7: Global IVF Treatment Costs by Regions; 2014 (US$)
Figure 8: Global Fertility Rates by Regions; 2014
Figure 9: Global IVF Penetration (woman undertaking IVF as % of total births); 2013
Figure 10: Global IVF Market by Segments; 2013
Figure 11: Global IVF Market by Key Players; 2013
Figure 13: Australia Number of IVF Cycles per Women; 2009-2014
Figure 12: Australia Number of Fresh IVF Cycles per Women by Age Group; 2013
Figure 14: Australia IVF Market Size by Value; 2010-2014 (US$ Million)
Figure 15: Australia IVF Market Size by Value; 2015E-2019E (US$ Million)
Figure 16: Australia and New Zealand IVF Market Size by Number of IVF Cycles; 2008-2013
Figure 17: Australia & New Zealand IVF Market Size by Number of IVF Cycles; 2014E-2019E
Figure 18: Australia Female Population by Age Group; 2003-2013 (Millions)
Figure 19: IVF Penetration in Australia; 2002-2013
Figure 20: Australia Fertility Rates; 2005-2013 (births per women)
Figure 21: India IVF Market by Value; 2012-2014 (US$ Million)
Figure 22: India IVF Market by Value; 2015E-2019E (US$ Million)
Figure 23: India IVF Market by No. of IVF Cycles; 2014-2019E (in 000s)
Figure 24: India Fertility Rates; 2010-2014 (births per women)
Figure 25: The US Fertility Treatment Costs; 2014 (US$)
Figure 26: Cumulative Success Rate of IVF Procedure in the US; 2014
Figure 27: The US IVF Market by Value; 2010-2014 (US$ Billion)
Figure 28: The US IVF Market by Value; 2015E-2019E (US$ Billion)
Figure 29: The US IVF Market Size by Number of IVF Procedures; 2002-2014 (in 000s)
Figure 30: The US IVF Market Size by Number of IVF Procedures; 2014E-2019E (in 000s)
Figure 31: The US IVF Market Size by Number of Infants Births by Using IVF; 2002-2014 (in 000s)
Figure 32: The US IVF Market Size by Number of Infants Births by Using IVF; 2015E-2019E (in 000s)
Figure 33: Number of IVF Cycles in the US by Age Group; 2013
Figure 34: Average No. of Embryos Transferred in the US; 2013
Figure 35: Percentage of Transfers Resulting in Live Births in the US; 2013
Figure 36: The US Birth Rates by Age of Women; 1990-2013 (%)
Figure 37: The US Fertility Rates; 2005-2013
Figure 38: Infertility Rates by Age; 2014
Figure 39: Same Sex Married Couples in the US; 2008-2013
Figure 40: Growing Prevalence of Obesity among US Adults; 2012-2030
Figure 41: Global Fertility Rates; 1960-2015E
Figure 42: Global Birth Rate per 1000 Women; 1950-2013
Figure 43: Decline in Male Fertility with Age
Figure 44: Global Healthcare Expenditure, 2005-2013 (US$ Trillion)
Figure 45: GDP per Capita, 2003-2013 (US$)
Figure 46: Success Rates for IVF Treatments; 2013
Figure 47: The UK Live Birth Rates, 1992-2010
Figure 48: Monash Net Revenue; 2012-2014 (US$ Million)
Figure 49: Monash Net Revenue Breakdown; 2012-2014 (US$ Million)
Figure 50: Number of IVF Cycles vs. Revenue per Cycle; 2012-2016E
Figure 51: Monash Group Number of PGD/PGS Procedures; 2011-2014
Figure 52: Vitrolife Net Revenue; 2010-2014 (US$ Million)
Figure 53: OvaScience Net Revenue; 2015-2020E (US$ Million)

  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
  • Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
  • Global Contraceptives Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
  • Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
  • Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
  • Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139
    Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
  • Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
  • Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
  • Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs